| Original language | French |
|---|---|
| Pages (from-to) | 189 |
| Journal | Drugs of the future |
| Volume | 35 |
| Issue number | suppl A |
| Publication status | Published - 2010 |
| Event | EFMC-ISMC 2010
XXIst INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY - Bruxelles, Belgium Duration: 5 Sep 2010 → … |
Cite this
}
Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy. / Moineaux, Laurence; Charlier, Caroline; Dolušić, Eduard; Larrieu, Pierre; Pilotte, Luc; Colaux, Didier; Stroobant, Vincent; Galleni, Moreno; Masereel, Bernard; Van den Eynde, Benoît; Wouters, Johan; Frédérick, Raphaël.
In: Drugs of the future, Vol. 35, No. suppl A, 2010, p. 189.Research output: Contribution to journal › Literature review
TY - JOUR
T1 - Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.
AU - Moineaux, Laurence
AU - Charlier, Caroline
AU - Dolušić, Eduard
AU - Larrieu, Pierre
AU - Pilotte, Luc
AU - Colaux, Didier
AU - Stroobant, Vincent
AU - Galleni, Moreno
AU - Masereel, Bernard
AU - Van den Eynde, Benoît
AU - Wouters, Johan
AU - Frédérick, Raphaël
PY - 2010
Y1 - 2010
M3 - Revue de documentation
VL - 35
SP - 189
JO - Drugs of the future
JF - Drugs of the future
SN - 0377-8282
IS - suppl A
ER -